Call Us : +919426709766
nikunj@jairadhesales.com
Atorvastatin Calcium

Atorvastatin Calcium

10750 INR/Kilograms

Product Details:

  • Medicine Name Atorvastatin Calcium
  • Type Pharmaceutical Intermediates
  • Physical Form Powder
  • Click to view more
X

Atorvastatin Calcium Price And Quantity

  • 25 Kilograms
  • 10750 INR/Kilograms

Atorvastatin Calcium Product Specifications

  • Powder
  • Atorvastatin Calcium
  • Pharmaceutical Intermediates

Atorvastatin Calcium Trade Information

  • 500 Kilograms Per Day
  • 1 Days

Product Description

Atorvastatin Calcium

Atorvastatin calcium is a selective and competitive HMGCR (HMG-CoA reductase) inhibitor, the rate-controlling enzyme of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. Inhibition of HMG-CoA reductase leads to drastic reduction in cholesterol and other isoprenoids production. Competitive inhibitors of the reductase can induce the expression of LDL (Low Density Lipoprotein) receptors in the liver, that increases the plasma LDLs catabolism and lowers the cholesterols plasma concentration. 

NAME :- ATORVASTATIN CALCIUM

IUPAC NAME :- (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicacid

CAS NO. :- 134523-03-8

FORMULA :- C66H68CAF2N4O10

SYNONYMS :- Tahor;ci-981;YM-548;Sortis;;pd134298-38a;ATORVASTATIN CA;Atorvastatin 3S,5S-Atorvastatin;Alorvastin calcium

APPLICATION :- The primary uses of atorvastatin is for the treatment of dyslipidemia and the prevention of cardiovascular disease.

DESCRIPTION :- Atorvastatin Calcium chemical compound is a selective and competitive HMGCR (HMG-CoA reductase) inhibitor, the rate-controlling enzyme of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. Inhibition of HMG-CoA reductase results in a drastic reduction in the production of cholesterol and other isoprenoids. Competitive inhibitors of the reductase are believed to induce the expression of LDL (Low Density Lipoprotein) receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol.

Product details 

Bioavailability

12%

Molecular Formula

C66H68CAF2N4O10

IUPAC Name

(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihyd

CAS Number

134523-03-8

Bioavailability

12%

Molecular Formula

C66H68CAF2N4O10

IUPAC Name

(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihyd

CAS Number

134523-03-8

 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Active Pharmaceutical Ingredients' category



Back to top